On January 29, 2024, Intelligent Bio Solutions Inc., a Delaware-incorporated medical technology company listed on the Nasdaq Stock Market under the symbol INBS, announced the adoption of its Intelligent Fingerprinting Drug Screening System by James Jones & Sons Ltd, a leading UK timber processor and packaging manufacturer. The system, which analyzes fingerprint sweat to detect drug use, will be used across James Jones & Sons Ltd's 25 UK sites and for its 1,300 employees as part of a new substance misuse policy. The policy, which includes random testing, was introduced to enhance workplace safety, particularly for employees operating high-risk machinery. The portable system allows for in-house, non-invasive, and rapid drug testing, providing results within ten minutes. The announcement was made through...Show More

On January 29, 2024, Intelligent Bio Solutions Inc., a Delaware-incorporated medical technology company listed on the Nasdaq Stock Market under the symbol INBS, announced the adoption of its Intelligent Fingerprinting Drug Screening System by James Jones & Sons Ltd, a leading UK timber processor and packaging manufacturer. The system, which analyzes fingerprint sweat to detect drug use, will be used across James Jones & Sons Ltd's 25 UK sites and for its 1,300 employees as part of a new substance misuse policy. The policy, which includes random testing, was introduced to enhance workplace safety, particularly for employees operating high-risk machinery. The portable system allows for in-house, non-invasive, and rapid drug testing, providing results within ten minutes. The announcement was made through a press release, which is attached as Exhibit 99.1 to the Form 8-K filed with the SEC. Intelligent Bio Solutions Inc. highlighted the system's ease of use and efficiency, noting its potential for broader applications in safety-critical industries. The company's Australian operations are also considering the system, indicating possible international expansion.